Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism
Giulia D’Intino(Hesperia Hospital), Laura Calzà(University of Bologna), G. Perretta(Institute of Neurobiology and Molecular Medicine), Alessandra Taglioni(Institute of Neurobiology and Molecular Medicine), Mercedes Fernández(University of Ferrara), Pablo Villoslada(Hospital Del Mar), Luciana Giardino, Luca Lorenzini(Fatebenefratelli Hospital), Giovanna Del Vecchio(Instituto Tecnológico de Buenos Aires (ITBA))
Cited by 39
Related Papers
Multiple Sclerosis Severity Score
|Neurology|2005|959
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.
|PubMed|2000|428
Endocrine Disrupters: A Review of Some Sources, Effects, and Mechanisms of Actions on Behaviour and Neuroendocrine Systems
|Journal of Neuroendocrinology|2011|425